Access to Health Care | Tokio X'press - Part 9

COVID-19：富士フイルム､AVIGANの治験を再実施へ：日本で4月に（動画）：　 COVID-19:Fujifilm to re-execute AVIGAN clinical trials:in April in Japan: COVID-19：Fujifilm重新执行AVIGAN临床试验：4月在日本

2021年02月27日By Tokio X'press flu, Product Safety & Quality, Insuring Health & Demographic Risk, Access to Health Care, Drugs, Pharmaceutical

COVID-19：スコットランドでファビピラビルの治験：NHS：（動画）：　 Investigate Favipiravir as Onset Treat for Mild to Moderate in Scotland: NHS研究Favipiravir作为苏格兰轻度至中度COVID-19的早期发作治疗

2021年02月25日By Tokio X'press flu, Product Safety & Quality, Responsible Investment, Access to Health Care, Drugs, Pharmaceutical

COVID-19：ロシュの関節炎治療薬トシリズマブ：死亡リスクを軽減（動画）：　 RECOVERY Data Shows Roche Tocilizumab Cuts Deaths in COVID-19 Patients: 恢复试验数据表明罗氏关节炎药物可减少住院的COVID-19患者的死亡

2021年02月22日By Tokio X'press flu, Health & Safety, Product Safety & Quality, Access to Health Care, Pharmaceutical

理研：毛髪再生につながる毛包幹細胞の培養手法を確立（動画）：　 RIKEN：Hair follicle stem cell culture method：leads to hair regeneration: RIKEN建立了毛囊干细胞培养方法，可促进头发再生

2021年02月19日By Tokio X'press Health & Safety, Product Safety & Quality, Insuring Health & Demographic Risk, Access to Health Care, Medical science

大阪大：ｉＰＳで目の結膜細胞作製：ドライアイの創薬に期待（動画）：　 Osaka Univ: Making eye conjunctival cells with iPS: for drug of dry eye: 大阪大学：使用iPS制作眼结膜细胞：对干眼症药物发现的期望

2021年02月15日By Tokio X'press Health & Safety, 1.Product Liability, Product Safety & Quality, Access to Health Care, Opportunities in Nutrition & Health, IPS, Medical science, Pharmaceutical

1 … 8 9 10 11